Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.

Literature DB >> 16804836

Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.

Rocus R Klont¹, Monique A S H Mennink-Kersten, Dorien Ruegebrink, Antonius J M M Rijs, Nicole M A Blijlevens, J Peter Donnelly, Paul E Verweij.

Abstract

A paradoxical increase in circulating Aspergillus antigen was observed during treatment with caspofungin in a patient with proven invasive aspergillosis. With the exception of treatment with the echinocandin, no other factors were found that might explain this clinical observation, which was supported by experiments done in vitro.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16804836 DOI： 10.1086/505603

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

Keyword Cloud
Cited

14 in total

1. Caspofungin: cross-reactivity in the Aspergillus antigen assay.

Authors: J Steinmann; J Buer; P-M Rath
Journal: J Clin Microbiol Date: 2010-03-31 Impact factor: 5.948

Review 2. Resistance to echinocandin-class antifungal drugs.

Authors: David S Perlin
Journal: Drug Resist Updat Date: 2007-06-13 Impact factor: 18.500

3. Clinical utility and development of biomarkers in invasive aspergillosis.

Authors: Thomas F Patterson
Journal: Trans Am Clin Climatol Assoc Date: 2011

Review 4. Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors: Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal: Clin Microbiol Rev Date: 2014-07 Impact factor: 26.132

5. The chitin synthase genes chsA and chsC are not required for cell wall stress responses in the human pathogen Aspergillus fumigatus.

Authors: Luise E Rogg; Jarrod R Fortwendel; Praveen Rao Juvvadi; Amanda Lilley; William J Steinbach
Journal: Biochem Biophys Res Commun Date: 2011-07-05 Impact factor: 3.575

10. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.

Authors: R Y Hachem; D P Kontoyiannis; R F Chemaly; Y Jiang; R Reitzel; I Raad
Journal: J Clin Microbiol Date: 2008-11-12 Impact factor: 5.948

Paradoxical increase in circulating Aspergillus antigen during treatment with caspofungin in a patient with pulmonary aspergillosis.

1. Caspofungin: cross-reactivity in the Aspergillus antigen assay.

Review 2. Resistance to echinocandin-class antifungal drugs.

3. Clinical utility and development of biomarkers in invasive aspergillosis.

Review 4. Molecular and nonmolecular diagnostic methods for invasive fungal infections.

5. The chitin synthase genes chsA and chsC are not required for cell wall stress responses in the human pathogen Aspergillus fumigatus.

6. In vitro activity and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus.

Review 7. Current perspectives on echinocandin class drugs.

8. Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure.

9. Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.

10. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.